<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02157779</url>
  </required_header>
  <id_info>
    <org_study_id>D1146-R</org_study_id>
    <secondary_id>Rx 001146</secondary_id>
    <nct_id>NCT02157779</nct_id>
  </id_info>
  <brief_title>Treatment of Trauma-Related Anger in OEF/OIF/OND Veterans</brief_title>
  <acronym>TOTRA</acronym>
  <official_title>Treatment of Trauma-Related Anger in OEF/OIF/OND Veterans</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>VA Office of Research and Development</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>VA Office of Research and Development</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Excessive and poorly controlled anger is one of the most common problems experienced by war
      Veterans. The consequences can be severe, including increased risk for divorce, domestic
      violence, job loss and instability, and other serious impairments in family, social, and
      occupational functioning. Availability of effective treatments is critical to reducing the
      adverse effects of anger in Veterans. The investigators propose to conduct a controlled study
      to determine whether a cognitive behavior treatment that has been adapted for treating anger
      problems in Veterans of Iraq and Afghanistan results in improved outcomes compared to a
      supportive therapy. Results will be examined for improvement in anger, functioning, and
      quality of life at end of 12 weekly sessions, and at 3 and 6 months following treatment.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Poorly controlled anger is a common problem with often devastating effects in Veterans who
      have served in a warzone. Adverse consequences include increased risk for divorce, domestic
      violence, job loss and instability, and other serious impairments in family, social, and
      occupational functioning. Recent evidence indicates that anger and aggression are likely to
      be problems for a significant proportion of Veterans of Iraq (Operation Iraqi Freedom, OIF;
      Operation New Dawn, OND) and Afghanistan (Operation Enduring Freedom, OEF). A survey of
      reintegration problems among 754 OEF/OIF combat Veterans receiving VA Medical care showed
      that anger was the most commonly reported problem, with 57% reporting increased problems in
      controlling anger. Despite encouraging evidence for efficacy of cognitive behavioral
      interventions in treating anger in civilian samples, much less is known about the efficacy of
      such treatments for anger problems in military personnel following exposure to war zone
      trauma. Promising preliminary findings for individually based cognitive behavioral treatment
      have been reported, and there is evidence that a group anger management treatment delivered
      by teleconferencing is as effective as the same treatment delivered in person, but to date
      there is not a single adequately powered randomized trial designed to test the efficacy of an
      anger treatment compared to an active control condition in Veterans. Building on findings
      from the investigators' randomized pilot study, the objective of the current proposal is to
      conduct a randomized clinical trial with sufficient statistical power to test the
      effectiveness of a manualized cognitive behavioral intervention (CBI) that has been adapted
      from an existing treatment (Anger Control Therapy; Novaco, 1994, 2001) for the treatment of
      anger problems in OEF/OIF/OND Veterans, compared to a manualized supportive therapy
      intervention (SI) control condition. Ninety OEF/OIF/OND Veterans reporting significant
      problems with anger will be randomized to receive 12 individual sessions of one of the two
      study conditions. Outcomes including measures of anger and aggression; interpersonal, social
      and occupational functioning; and quality of life will be assessed during and at the end of
      treatment and at 3 and 6 month follow-ups. Exploratory analyses will examine 1) whether a
      diagnosis of PTSD impacts treatment effectiveness and 2) potential mediators of treatment
      outcome with CBI.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2015</start_date>
  <completion_date type="Actual">February 28, 2019</completion_date>
  <primary_completion_date type="Actual">February 28, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change From Baseline in Anger on the State Trait Anger Inventory 2 (STAXI-2) - Anger Expression Index Score</measure>
    <time_frame>Baseline, Weeks 4, 8,12, 3 and 6 months post-treatment</time_frame>
    <description>The STAXI-2 is a revision of Spielberger's State-Trait Anger Expression Inventory (STAXI), expanded from 44 to 57 items. It is a self-report questionnaire consisting of six scales and an Anger Expression Index (AX). Scales include State Anger, Trait Anger, Anger Expression-Out, Anger Expression-In, Anger Control-Out and Anger Expression-In. The Anger Expression Index is an overall measure of the expression and control of anger based on responses to the two anger expression and the two anger control subscales.Minimum and Maximum Values range from 0 to 96, higher scores mean more anger.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Overt Aggression Scale-Modified (OAS-M) - Aggression Scale Score</measure>
    <time_frame>Baseline, Weeks 4, 8,12, 3 and 6 months post-treatment</time_frame>
    <description>Structured Interview that assesses verbal and physical aggressive behaviors. Minimum and Maximum Values range from 0 to no maximum, higher scores mean more anger.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline in Social Functioning on the Longitudinal Interval Follow-up Evaluation (LIFE) Global Social Score</measure>
    <time_frame>Baseline, 12 weeks, 3 and 6 months post-treatment</time_frame>
    <description>Psychosocial functioning scales from the clinician administered Longitudinal Interval Follow-up Evaluation (LIFE) provides assessment of functioning in areas of work (employment, household, or student), familial and nonfamilial interpersonal relationships, recreation, and global social adjustment on separate 6 to 8-point scales. Ratings will be based on the past month. The psychosocial functioning ratings have been found to be of generally high reliability. Minimum and Maximum Values range from 1 to 5, higher scores mean worse functioning.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline in Work Functioning on the Longitudinal Interval Follow-up Evaluation (LIFE) Global Employment Score</measure>
    <time_frame>Baseline, 12 weeks, 3 and 6 months post-treatment</time_frame>
    <description>Psychosocial functioning scales from the clinician administered Longitudinal Interval Follow-up Evaluation (LIFE) provides assessment of functioning in areas of work (employment, household, or student), familial and nonfamilial interpersonal relationships, recreation, and global social adjustment on separate 6 to 8-point scales. Ratings will be based on the past month. The psychosocial functioning ratings have been found to be of generally high reliability. Minimum and Maximum Values range from 1 to 5, higher scores mean worse functioning.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline in Interpersonal and Social Functioning on the Outcomes Questionnaire (OQ)-Total Score</measure>
    <time_frame>Baseline, 12 weeks, 3 and 6 months post-treatment</time_frame>
    <description>The OQ is a self report measure that assesses functioning and includes three subscales: symptom distress, interpersonal relations, and social role functioning. Concurrent validity has been demonstrated in relation to internal consistency and reliability. Additionally, the OQ has been shown to be fairly stable in untreated individuals and sensitive to change in those individuals in treatment. Minimum and Maximum Values range from 0 to 180, higher scores mean worse functioning.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline in Quality of Life From WHO Quality of Life (WHOQOL) - Psychological</measure>
    <time_frame>Baseline, 12 weeks, 3 and 6 months post-treatment</time_frame>
    <description>The World Health Organization Quality of Life (WHOQOL-BREF), is 26 item self-report measure used to assess quality of life in multiple domains (i.e., physical, psychological, social, and environment). Psychometric properties suggest that the measure is valid and reliable across cultures and nations. Minimum and Maximum Values range from 6 to 30, higher scores mean better quality of life.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline in PTSD Symptoms on the Clinician-Administered PTSD Scale (CAPS) for DSM-5 Total Score</measure>
    <time_frame>Baseline,12 weeks, 3 and 6 months post-treatment</time_frame>
    <description>The CAPS-5 (updated for DSM-5) is a clinician administered structured interview for the assessment of DSM-5 PTSD. The CAPS has excellent reliability and validity and is widely used in PTSD treatment research. Each one of the DSM-5 PTSD symptoms is rated on a 0-4 (low to high) scale to determine symptom severity. The cutoff used to establish the presence of an individual symptom is a score of 2 or greater. Overall PTSD severity is computed by summing the totals for all items. Minimum and Maximum Values range from 0 to 80, higher scores mean higher levels of symptomatology.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Change From Baseline in Anger on the Anger Consequences Questionnaire (ACQ)Total Score</measure>
    <time_frame>Baseline, Week 12, 3 and 6 months Post-treatment</time_frame>
    <description>The ACQ is a brief self-report measure developed to assess the frequency of negative anger-related behavioral consequences. Internal consistencies of .75 to .91 were reported on the original 42 item version; the revised version shortened the measure to 33 items based on factor analysis. This scale includes items not covered by the other anger measures, including for example, trouble with the law, driving recklessly, getting into an accident, damaging relationships, etc. Minimum and Maximum Values range from 0 to 200, higher scores means more anger.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">112</enrollment>
  <condition>Anger Problems</condition>
  <arm_group>
    <arm_group_label>Cognitive Behavioral Intervention (CBI)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>12 weekly individual sessions consisting of psychoeducation, and cognitive and behavioral anger management strategies</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Supportive Intervention (SI)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>12 weekly individual sessions consisting of psychoeducation, problem-solving strategies, and support</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Cognitive Behavioral Intervention</intervention_name>
    <description>Includes individual therapy sessions using cognitive and behavioral strategies addressing problems with anger intensity / frequency / management</description>
    <arm_group_label>Cognitive Behavioral Intervention (CBI)</arm_group_label>
    <other_name>CBI</other_name>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Supportive Intervention</intervention_name>
    <description>Includes individual therapy sessions using supportive and problem-solving strategies.</description>
    <arm_group_label>Supportive Intervention (SI)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male or Female current or former member of the military (active duty, National Guard
             or Reserve) Deployed to Iraq or Afghanistan

          -  Experience trauma during deployment

          -  Clinically significant anger

          -  At least 2 additional symptoms of PTSD hyperarousal

          -  If on medication, no changes within prior 4 weeks

        Exclusion Criteria:

          -  Current severe substance use disorder or prior severe substance use disorder not in
             remission for at least 3 months

          -  Current psychotic symptoms

          -  current Mania or Bipolar Disorder

          -  Current suicidal or homicidal ideation requiring hospitalization

          -  Any severe cognitive impairment or history of Organic Mental Disorder
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tracie M. Shea, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Providence VA Medical Center, Providence, RI</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Providence VA Medical Center, Providence, RI</name>
      <address>
        <city>Providence</city>
        <state>Rhode Island</state>
        <zip>02908</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Shea MT, Lambert J, Reddy MK, Presseau C, Sevin E, Stout RL. Treatment of trauma related anger in operation enduring freedom, operation Iraqi freedom, and operation New Dawn veterans: Rationale and study protocol. Contemp Clin Trials Commun. 2018 Aug 24;12:26-31. doi: 10.1016/j.conctc.2018.08.011. eCollection 2018 Dec.</citation>
    <PMID>30225391</PMID>
  </reference>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>May 6, 2014</study_first_submitted>
  <study_first_submitted_qc>June 3, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 6, 2014</study_first_posted>
  <results_first_submitted>February 26, 2020</results_first_submitted>
  <results_first_submitted_qc>February 26, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">March 16, 2020</results_first_posted>
  <last_update_submitted>June 2, 2020</last_update_submitted>
  <last_update_submitted_qc>June 2, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 16, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Veterans</keyword>
  <keyword>Anger</keyword>
  <keyword>Cognitive Behavioral Therapy</keyword>
  <keyword>Treatment</keyword>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>I anticipate sharing the data, but have not yet developed a specific plan.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_time_frame>April 1 2021</ipd_time_frame>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>November 28, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/79/NCT02157779/Prot_SAP_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Informed Consent Form</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>September 18, 2017</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/79/NCT02157779/ICF_001.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Participants were recruited from a wide range of sources during the time period of January 1, 2015 through January 31, 2018. The primary recruitment source was the Providence Veterans Affairs Medical Center, including the OEF/OIF specialty primary care clinic, the Returning Veterans Outreach Program (REVOC) and the PTSD Clinic.</recruitment_details>
      <pre_assignment_details>Of the 112 enrolled, 94 completed both the first and second baseline assessments and were deemed eligible for the study. Of the 94 who completed their second baseline and were deemed eligible for the study, 92 were randomized to treatment. Two of the 92 randomized participants did not respond to outreach and did not start treatment.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Cognitive Behavioral Intervention</title>
          <description>12 weekly individual sessions consisting of psychoeducation, and cognitive and behavioral anger management strategies
Cognitive Behavioral Intervention: Includes individual therapy sessions using cognitive and behavioral strategies addressing problems with anger intensity / frequency / management</description>
        </group>
        <group group_id="P2">
          <title>Supportive Intervention</title>
          <description>12 weekly individual sessions consisting of psychoeducation, problem-solving strategies, and support
Supportive Intervention: Includes individual therapy sessions using supportive and problem-solving strategies.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="47"/>
                <participants group_id="P2" count="45"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="23"/>
                <participants group_id="P2" count="34"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="24"/>
                <participants group_id="P2" count="11"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Logistical</title>
              <participants_list>
                <participants group_id="P1" count="9"/>
                <participants group_id="P2" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Stopped attending, reason unknown</title>
              <participants_list>
                <participants group_id="P1" count="11"/>
                <participants group_id="P2" count="7"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>No response to outreach after Baseline</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Moved</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Medical</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Legal issue</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Number of participants varies slightly for some measures due to missing data.</population>
      <group_list>
        <group group_id="B1">
          <title>Cognitive Behavioral Intervention</title>
          <description>12 weekly individual sessions consisting of psychoeducation, and cognitive and behavioral anger management strategies
Cognitive Behavioral Intervention: Includes individual therapy sessions using cognitive and behavioral strategies addressing problems with anger intensity / frequency / management</description>
        </group>
        <group group_id="B2">
          <title>Supportive Intervention</title>
          <description>12 weekly individual sessions consisting of psychoeducation, problem-solving strategies, and support
Supportive Intervention: Includes individual therapy sessions using supportive and problem-solving strategies.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="47"/>
            <count group_id="B2" value="45"/>
            <count group_id="B3" value="92"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="35.30" spread="9.11"/>
                    <measurement group_id="B2" value="36.5" spread="9.77"/>
                    <measurement group_id="B3" value="35.90" spread="9.41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="46"/>
                    <measurement group_id="B2" value="43"/>
                    <measurement group_id="B3" value="89"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="12"/>
                    <measurement group_id="B3" value="19"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="40"/>
                    <measurement group_id="B2" value="33"/>
                    <measurement group_id="B3" value="73"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="4"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="5"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="42"/>
                    <measurement group_id="B2" value="35"/>
                    <measurement group_id="B3" value="77"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="5"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Employment Status</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Full Time</title>
                  <measurement_list>
                    <measurement group_id="B1" value="22"/>
                    <measurement group_id="B2" value="27"/>
                    <measurement group_id="B3" value="49"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Part Time</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="20"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unemployed</title>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="17"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Retired</title>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Education</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>High School Graduate/GED</title>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                    <measurement group_id="B2" value="11"/>
                    <measurement group_id="B3" value="22"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Some College/Technical School</title>
                  <measurement_list>
                    <measurement group_id="B1" value="30"/>
                    <measurement group_id="B2" value="24"/>
                    <measurement group_id="B3" value="54"/>
                  </measurement_list>
                </category>
                <category>
                  <title>College Graduate</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="11"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Post Graduate</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>State Trait Anger Inventory 2 (STAXI-2) Anger Expression Index Score</title>
          <description>STAXI-2 is a self-report questionnaire consisting of six scales and an Anger Expression Index. The Anger Expression Index is an overall measure of the expression and control of anger based on responses to two anger expression and two anger control subscales. Score range is 0 to 96; higher scores means more anger.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="55.67" spread="12.98"/>
                    <measurement group_id="B2" value="54.77" spread="11.86"/>
                    <measurement group_id="B3" value="55.24" spread="12.39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Overt Anger Scale-Modified Aggression Scale</title>
          <description>Structured Interview that assesses verbal and physical aggressive behaviors. Four subscores are calculated by multiplying frequency by severity of specific behaviors within that category. Subscores are also weighted for severity. The Aggression Scale Score is the total of subscores. Minimum score is zero; no maximum score specified as scores are determined by unlimited frequency counts of behavior. Higher scores indicate more frequent and severe aggressive behaviors.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1.335" spread="0.525"/>
                    <measurement group_id="B2" value="1.396" spread="0.500"/>
                    <measurement group_id="B3" value="1.365" spread="0.511"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Longitudinal Interval Follow up (LIFE) social functioning global score</title>
          <description>LIFE psychosocial functioning scales assess functioning in multiple areas, including work, interpersonal relationships, recreation, and global social adjustment. The global social adjustment score ranges from 1 to 5, with higher scores reflecting poorer functioning.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3.57" spread="0.54"/>
                    <measurement group_id="B2" value="3.64" spread="0.71"/>
                    <measurement group_id="B3" value="3.61" spread="0.63"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>LIFE Work Functioning Global Score</title>
          <description>The LIFE Work Functioning Score assess functioning in work (employment, household, or student). The work global score ranges from 1 to 5; higher scores indicate worse functioning.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3.17" spread="1.22"/>
                    <measurement group_id="B2" value="2.98" spread="1.08"/>
                    <measurement group_id="B3" value="3.08" spread="1.15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Outcomes Questionnaire</title>
          <description>The Outcomes questionnaire is a self report measure that assesses functioning and includes three subscales: symptom distress, interpersonal relations, and social role functioning. The total score is the sum of the scores for the three scales. Total scores can range from 0 to 180; higher scores mean worse functioning.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="82.45" spread="26.50"/>
                    <measurement group_id="B2" value="88.31" spread="22.93"/>
                    <measurement group_id="B3" value="85.32" spread="24.86"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>WHO Quality of Life (WHOQOL) Psychological Domain</title>
          <description>The WHOQOL is a 26 item self report measure used to assess quality of life in multiple domains. The psychological domain includes 6 items, each rated on a scale from 1 to 5, for a range of 6 to 30. Higher scores reflect better quality of life.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="17.87" spread="3.72"/>
                    <measurement group_id="B2" value="17.45" spread="3.11"/>
                    <measurement group_id="B3" value="17.67" spread="3.42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Clinician Administered PTSD Scale (CAPS)</title>
          <description>The CAPS-5 is a clinician administered structured interview assessing the DSM-5 PTSD symptoms. Each of the 20 symptoms is rated on a 0 to 4 scale; the range for the total score is 0 to 80. Higher scores reflect more severe PTSD.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="30.02" spread="10.62"/>
                    <measurement group_id="B2" value="32.38" spread="9.52"/>
                    <measurement group_id="B3" value="31.17" spread="10.11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline in Anger on the State Trait Anger Inventory 2 (STAXI-2) - Anger Expression Index Score</title>
        <description>The STAXI-2 is a revision of Spielberger's State-Trait Anger Expression Inventory (STAXI), expanded from 44 to 57 items. It is a self-report questionnaire consisting of six scales and an Anger Expression Index (AX). Scales include State Anger, Trait Anger, Anger Expression-Out, Anger Expression-In, Anger Control-Out and Anger Expression-In. The Anger Expression Index is an overall measure of the expression and control of anger based on responses to the two anger expression and the two anger control subscales.Minimum and Maximum Values range from 0 to 96, higher scores mean more anger.</description>
        <time_frame>Baseline, Weeks 4, 8,12, 3 and 6 months post-treatment</time_frame>
        <population>Participants were randomly assigned to CBI or SI. Participants with at least one post-baseline measure (4wk, 8wk, end of treatment, 3 mo f/u, and/or 6 mo f/u) were included in HLM analysis. 25 participants (15 CBI, 10 SI) did not have post-baseline data on this scale. Mean scores / SDs are shown for all participants with data at each time point.</population>
        <group_list>
          <group group_id="O1">
            <title>Cognitive Behavioral Intervention</title>
            <description>12 weekly individual sessions consisting of psychoeducation, and cognitive and behavioral anger management strategies
Cognitive Behavioral Intervention: Includes individual therapy sessions using cognitive and behavioral strategies addressing problems with anger intensity / frequency / management</description>
          </group>
          <group group_id="O2">
            <title>Supportive Intervention</title>
            <description>12 weekly individual sessions consisting of psychoeducation, problem-solving strategies, and support
Supportive Intervention: Includes individual therapy sessions using supportive and problem-solving strategies.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Anger on the State Trait Anger Inventory 2 (STAXI-2) - Anger Expression Index Score</title>
          <description>The STAXI-2 is a revision of Spielberger's State-Trait Anger Expression Inventory (STAXI), expanded from 44 to 57 items. It is a self-report questionnaire consisting of six scales and an Anger Expression Index (AX). Scales include State Anger, Trait Anger, Anger Expression-Out, Anger Expression-In, Anger Control-Out and Anger Expression-In. The Anger Expression Index is an overall measure of the expression and control of anger based on responses to the two anger expression and the two anger control subscales.Minimum and Maximum Values range from 0 to 96, higher scores mean more anger.</description>
          <population>Participants were randomly assigned to CBI or SI. Participants with at least one post-baseline measure (4wk, 8wk, end of treatment, 3 mo f/u, and/or 6 mo f/u) were included in HLM analysis. 25 participants (15 CBI, 10 SI) did not have post-baseline data on this scale. Mean scores / SDs are shown for all participants with data at each time point.</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="32"/>
                <count group_id="O2" value="35"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Week 4</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="31"/>
                    <count group_id="O2" value="34"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="49.16" spread="15.30"/>
                    <measurement group_id="O2" value="52.88" spread="12.82"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 8</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="25"/>
                    <count group_id="O2" value="31"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="40.33" spread="17.95"/>
                    <measurement group_id="O2" value="49.61" spread="13.89"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>End of Treatment (Week 12)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="24"/>
                    <count group_id="O2" value="33"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="37.50" spread="16.68"/>
                    <measurement group_id="O2" value="46.00" spread="13.64"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 Months Post</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="17"/>
                    <count group_id="O2" value="29"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="40.31" spread="14.07"/>
                    <measurement group_id="O2" value="43.81" spread="13.85"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 Months Post</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="29"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="42.06" spread="15.27"/>
                    <measurement group_id="O2" value="44.61" spread="14.20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>.0199</p_value>
            <p_value_desc>Threshold for statistical significance was 0.025.</p_value_desc>
            <method>ANCOVA</method>
            <method_desc>Method used: Hierarchical Linear Model (HLM) Repeated Measures Analysis of Covariance, Controlling for Baseline Score</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Overt Aggression Scale-Modified (OAS-M) - Aggression Scale Score</title>
        <description>Structured Interview that assesses verbal and physical aggressive behaviors. Minimum and Maximum Values range from 0 to no maximum, higher scores mean more anger.</description>
        <time_frame>Baseline, Weeks 4, 8,12, 3 and 6 months post-treatment</time_frame>
        <population>Participants were randomly assigned to CBI or SI. Participants with at least one post-baseline measure (4wk, 8wk, end of treatment, 3 mo f/u, and/or 6 mo f/u) were included in HLM analysis. 25 participants (13 CBI, 6 SI) did not have post-baseline data on this scale. Mean scores / SDs are shown for all participants with data at each time point.</population>
        <group_list>
          <group group_id="O1">
            <title>Cognitive Behavioral Intervention</title>
            <description>12 weekly individual sessions consisting of psychoeducation, and cognitive and behavioral anger management strategies
Cognitive Behavioral Intervention: Includes individual therapy sessions using cognitive and behavioral strategies addressing problems with anger intensity / frequency / management</description>
          </group>
          <group group_id="O2">
            <title>Supportive Intervention</title>
            <description>12 weekly individual sessions consisting of psychoeducation, problem-solving strategies, and support
Supportive Intervention: Includes individual therapy sessions using supportive and problem-solving strategies.</description>
          </group>
        </group_list>
        <measure>
          <title>Overt Aggression Scale-Modified (OAS-M) - Aggression Scale Score</title>
          <description>Structured Interview that assesses verbal and physical aggressive behaviors. Minimum and Maximum Values range from 0 to no maximum, higher scores mean more anger.</description>
          <population>Participants were randomly assigned to CBI or SI. Participants with at least one post-baseline measure (4wk, 8wk, end of treatment, 3 mo f/u, and/or 6 mo f/u) were included in HLM analysis. 25 participants (13 CBI, 6 SI) did not have post-baseline data on this scale. Mean scores / SDs are shown for all participants with data at each time point.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="34"/>
                <count group_id="O2" value="39"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Week 4</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="31"/>
                    <count group_id="O2" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.234" spread="0.486"/>
                    <measurement group_id="O2" value="1.285" spread="0.541"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 8</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="25"/>
                    <count group_id="O2" value="33"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.953" spread="0.639"/>
                    <measurement group_id="O2" value="1.148" spread="0.638"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>End of Treatment (Week 12)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="25"/>
                    <count group_id="O2" value="34"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.909" spread="0.608"/>
                    <measurement group_id="O2" value="1.103" spread="0.662"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 Months Post</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="19"/>
                    <count group_id="O2" value="30"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.908" spread="0.448"/>
                    <measurement group_id="O2" value="1.024" spread="0.728"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 Months Post</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="19"/>
                    <count group_id="O2" value="34"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.946" spread="0.758"/>
                    <measurement group_id="O2" value="1.117" spread="0.549"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Population Description: All randomized participants with at least one post-baseline assessment were used in the statistical analysis process. Data was winsorized and log10 transformed to counter high levels of skewness.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.182</p_value>
            <p_value_desc>The threshold for statistical significance was p=0.025</p_value_desc>
            <method>ANCOVA</method>
            <method_desc>Hierarchical Linear Model (HLM) Repeated Measures Analysis of Covariance, Controlling for Baseline Score</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline in Social Functioning on the Longitudinal Interval Follow-up Evaluation (LIFE) Global Social Score</title>
        <description>Psychosocial functioning scales from the clinician administered Longitudinal Interval Follow-up Evaluation (LIFE) provides assessment of functioning in areas of work (employment, household, or student), familial and nonfamilial interpersonal relationships, recreation, and global social adjustment on separate 6 to 8-point scales. Ratings will be based on the past month. The psychosocial functioning ratings have been found to be of generally high reliability. Minimum and Maximum Values range from 1 to 5, higher scores mean worse functioning.</description>
        <time_frame>Baseline, 12 weeks, 3 and 6 months post-treatment</time_frame>
        <population>Participants were randomly assigned to CBI or SI using Wei and Stout's urn randomization strategy. Participants with at least one post-baseline measure (i.e. one or more of end of treatment, 3 mo f/u, 6 mo f/u scores) were included in HLM analysis. Mean scores and SDs are shown for all participants with data at each assessment point.</population>
        <group_list>
          <group group_id="O1">
            <title>Cognitive Behavioral Intervention</title>
            <description>12 weekly individual sessions consisting of psychoeducation, and cognitive and behavioral anger management strategies
Cognitive Behavioral Intervention: Includes individual therapy sessions using cognitive and behavioral strategies addressing problems with anger intensity / frequency / management.</description>
          </group>
          <group group_id="O2">
            <title>Supportive Intervention</title>
            <description>12 weekly individual sessions consisting of psychoeducation, problem-solving strategies, and support
Supportive Intervention: Includes individual therapy sessions using supportive and problem-solving strategies.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Social Functioning on the Longitudinal Interval Follow-up Evaluation (LIFE) Global Social Score</title>
          <description>Psychosocial functioning scales from the clinician administered Longitudinal Interval Follow-up Evaluation (LIFE) provides assessment of functioning in areas of work (employment, household, or student), familial and nonfamilial interpersonal relationships, recreation, and global social adjustment on separate 6 to 8-point scales. Ratings will be based on the past month. The psychosocial functioning ratings have been found to be of generally high reliability. Minimum and Maximum Values range from 1 to 5, higher scores mean worse functioning.</description>
          <population>Participants were randomly assigned to CBI or SI using Wei and Stout's urn randomization strategy. Participants with at least one post-baseline measure (i.e. one or more of end of treatment, 3 mo f/u, 6 mo f/u scores) were included in HLM analysis. Mean scores and SDs are shown for all participants with data at each assessment point.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="27"/>
                <count group_id="O2" value="37"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>12 Weeks</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="25"/>
                    <count group_id="O2" value="34"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.92" spread="0.64"/>
                    <measurement group_id="O2" value="3.38" spread="0.78"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 Month Post</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="19"/>
                    <count group_id="O2" value="30"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.95" spread="0.78"/>
                    <measurement group_id="O2" value="3.27" spread="0.78"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 Month Post</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="19"/>
                    <count group_id="O2" value="34"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.79" spread="0.79"/>
                    <measurement group_id="O2" value="3.06" spread="0.92"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Population Description: All randomized participants with at least one post-baseline assessment were used in the statistical analysis process.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>.012</p_value>
            <p_value_desc>Threshold for statistical significance was 0.025.</p_value_desc>
            <method>ANCOVA</method>
            <method_desc>Hierarchical Linear Model (HLM) Repeated Measures Analysis of Covariance, Controlling for Baseline Score</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline in Work Functioning on the Longitudinal Interval Follow-up Evaluation (LIFE) Global Employment Score</title>
        <description>Psychosocial functioning scales from the clinician administered Longitudinal Interval Follow-up Evaluation (LIFE) provides assessment of functioning in areas of work (employment, household, or student), familial and nonfamilial interpersonal relationships, recreation, and global social adjustment on separate 6 to 8-point scales. Ratings will be based on the past month. The psychosocial functioning ratings have been found to be of generally high reliability. Minimum and Maximum Values range from 1 to 5, higher scores mean worse functioning.</description>
        <time_frame>Baseline, 12 weeks, 3 and 6 months post-treatment</time_frame>
        <population>Participants were randomly assigned to CBI or SI. Participants with at least one post-baseline measure (4wk, 8wk, end of treatment, 3 mo f/u, and/or 6 mo f/u) were included in HLM analysis. 28 participants (20 CBI, 8 SI) did not have post-baseline data on this scale. Mean scores / SDs are shown for all participants with data at each time point.</population>
        <group_list>
          <group group_id="O1">
            <title>Cognitive Behavioral Intervention</title>
            <description>12 weekly individual sessions consisting of psychoeducation, and cognitive and behavioral anger management strategies
Cognitive Behavioral Intervention: Includes individual therapy sessions using cognitive and behavioral strategies addressing problems with anger intensity / frequency / management.</description>
          </group>
          <group group_id="O2">
            <title>Supportive Intervention</title>
            <description>12 weekly individual sessions consisting of psychoeducation, problem-solving strategies, and support
Supportive Intervention: Includes individual therapy sessions using supportive and problem-solving strategies.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Work Functioning on the Longitudinal Interval Follow-up Evaluation (LIFE) Global Employment Score</title>
          <description>Psychosocial functioning scales from the clinician administered Longitudinal Interval Follow-up Evaluation (LIFE) provides assessment of functioning in areas of work (employment, household, or student), familial and nonfamilial interpersonal relationships, recreation, and global social adjustment on separate 6 to 8-point scales. Ratings will be based on the past month. The psychosocial functioning ratings have been found to be of generally high reliability. Minimum and Maximum Values range from 1 to 5, higher scores mean worse functioning.</description>
          <population>Participants were randomly assigned to CBI or SI. Participants with at least one post-baseline measure (4wk, 8wk, end of treatment, 3 mo f/u, and/or 6 mo f/u) were included in HLM analysis. 28 participants (20 CBI, 8 SI) did not have post-baseline data on this scale. Mean scores / SDs are shown for all participants with data at each time point.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="27"/>
                <count group_id="O2" value="37"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>12 Weeks</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="25"/>
                    <count group_id="O2" value="34"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.88" spread="0.88"/>
                    <measurement group_id="O2" value="3.21" spread="1.07"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 Month Post</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="19"/>
                    <count group_id="O2" value="30"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.05" spread="0.85"/>
                    <measurement group_id="O2" value="3.00" spread="0.95"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 Month Post</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="19"/>
                    <count group_id="O2" value="34"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.84" spread="0.90"/>
                    <measurement group_id="O2" value="2.71" spread="0.97"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>All randomized participants with at least one post-baseline assessment were used in the statistical analysis process.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.165</p_value>
            <p_value_desc>Threshold for statistical significance was 0.025.</p_value_desc>
            <method>ANCOVA</method>
            <method_desc>Hierarchical Linear Model (HLM) Repeated Measures Analysis of Covariance, Controlling for Baseline Score</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline in Interpersonal and Social Functioning on the Outcomes Questionnaire (OQ)-Total Score</title>
        <description>The OQ is a self report measure that assesses functioning and includes three subscales: symptom distress, interpersonal relations, and social role functioning. Concurrent validity has been demonstrated in relation to internal consistency and reliability. Additionally, the OQ has been shown to be fairly stable in untreated individuals and sensitive to change in those individuals in treatment. Minimum and Maximum Values range from 0 to 180, higher scores mean worse functioning.</description>
        <time_frame>Baseline, 12 weeks, 3 and 6 months post-treatment</time_frame>
        <population>Participants were randomly assigned to CBI or SI. Participants with at least one post-baseline measure (end of treatment, 3 mo f/u, and/or 6 mo f/u) were included in HLM analysis. 29 participants (21 CBI, 8 SI) did not have post-baseline data on this scale. Mean scores / SDs are shown for all participants with data at each time point.</population>
        <group_list>
          <group group_id="O1">
            <title>Cognitive Behavioral Intervention</title>
            <description>12 weekly individual sessions consisting of psychoeducation, and cognitive and behavioral anger management strategies
Cognitive Behavioral Intervention: Includes individual therapy sessions using cognitive and behavioral strategies addressing problems with anger intensity / frequency / management.</description>
          </group>
          <group group_id="O2">
            <title>Supportive Intervention</title>
            <description>12 weekly individual sessions consisting of psychoeducation, problem-solving strategies, and support
Supportive Intervention: Includes individual therapy sessions using supportive and problem-solving strategies.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Interpersonal and Social Functioning on the Outcomes Questionnaire (OQ)-Total Score</title>
          <description>The OQ is a self report measure that assesses functioning and includes three subscales: symptom distress, interpersonal relations, and social role functioning. Concurrent validity has been demonstrated in relation to internal consistency and reliability. Additionally, the OQ has been shown to be fairly stable in untreated individuals and sensitive to change in those individuals in treatment. Minimum and Maximum Values range from 0 to 180, higher scores mean worse functioning.</description>
          <population>Participants were randomly assigned to CBI or SI. Participants with at least one post-baseline measure (end of treatment, 3 mo f/u, and/or 6 mo f/u) were included in HLM analysis. 29 participants (21 CBI, 8 SI) did not have post-baseline data on this scale. Mean scores / SDs are shown for all participants with data at each time point.</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="26"/>
                <count group_id="O2" value="37"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>12 Weeks</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="24"/>
                    <count group_id="O2" value="34"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="60.50" spread="28.81"/>
                    <measurement group_id="O2" value="72.35" spread="26.44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 Month Post</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="30"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="58.17" spread="27.99"/>
                    <measurement group_id="O2" value="76.07" spread="26.31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 Month Post</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="32"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="61.17" spread="28.82"/>
                    <measurement group_id="O2" value="70.91" spread="27.18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>All randomized participants with at least one post-baseline assessment were used in the statistical analysis process.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>.064</p_value>
            <p_value_desc>Threshold for statistical significance was 0.025.</p_value_desc>
            <method>ANCOVA</method>
            <method_desc>Hierarchical Linear Model (HLM) Repeated Measures Analysis of Covariance, Controlling for Baseline Score</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline in Quality of Life From WHO Quality of Life (WHOQOL) - Psychological</title>
        <description>The World Health Organization Quality of Life (WHOQOL-BREF), is 26 item self-report measure used to assess quality of life in multiple domains (i.e., physical, psychological, social, and environment). Psychometric properties suggest that the measure is valid and reliable across cultures and nations. Minimum and Maximum Values range from 6 to 30, higher scores mean better quality of life.</description>
        <time_frame>Baseline, 12 weeks, 3 and 6 months post-treatment</time_frame>
        <population>Participants were randomly assigned to CBI or SI. Participants with at least one post-baseline measure (end of treatment, 3 mo f/u, and/or 6 mo f/u) were included in HLM analysis. 32 participants (22 CBI, 10 SI) did not have post-baseline data on this scale. Mean scores / SDs are shown for all participants with data at each time point.</population>
        <group_list>
          <group group_id="O1">
            <title>Cognitive Behavioral Intervention</title>
            <description>12 weekly individual sessions consisting of psychoeducation, and cognitive and behavioral anger management strategies
Cognitive Behavioral Intervention: Includes individual therapy sessions using cognitive and behavioral strategies addressing problems with anger intensity / frequency / management.</description>
          </group>
          <group group_id="O2">
            <title>Supportive Intervention</title>
            <description>12 weekly individual sessions consisting of psychoeducation, problem-solving strategies, and support
Supportive Intervention: Includes individual therapy sessions using supportive and problem-solving strategies.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Quality of Life From WHO Quality of Life (WHOQOL) - Psychological</title>
          <description>The World Health Organization Quality of Life (WHOQOL-BREF), is 26 item self-report measure used to assess quality of life in multiple domains (i.e., physical, psychological, social, and environment). Psychometric properties suggest that the measure is valid and reliable across cultures and nations. Minimum and Maximum Values range from 6 to 30, higher scores mean better quality of life.</description>
          <population>Participants were randomly assigned to CBI or SI. Participants with at least one post-baseline measure (end of treatment, 3 mo f/u, and/or 6 mo f/u) were included in HLM analysis. 32 participants (22 CBI, 10 SI) did not have post-baseline data on this scale. Mean scores / SDs are shown for all participants with data at each time point.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="25"/>
                <count group_id="O2" value="35"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>12 Weeks</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="24"/>
                    <count group_id="O2" value="33"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="20.33" spread="3.27"/>
                    <measurement group_id="O2" value="17.73" spread="3.37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 Month</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="17"/>
                    <count group_id="O2" value="29"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="19.82" spread="2.98"/>
                    <measurement group_id="O2" value="17.76" spread="3.53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 Month</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="31"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="19.72" spread="2.93"/>
                    <measurement group_id="O2" value="18.87" spread="3.39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>All randomized participants with at least one post-baseline assessment were used in the statistical analysis process.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.0247</p_value>
            <p_value_desc>Threshold for statistical significance was 0.025.</p_value_desc>
            <method>ANCOVA</method>
            <method_desc>Hierarchical Linear Model (HLM) Repeated Measures Analysis of Covariance, Controlling for Baseline Score</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline in PTSD Symptoms on the Clinician-Administered PTSD Scale (CAPS) for DSM-5 Total Score</title>
        <description>The CAPS-5 (updated for DSM-5) is a clinician administered structured interview for the assessment of DSM-5 PTSD. The CAPS has excellent reliability and validity and is widely used in PTSD treatment research. Each one of the DSM-5 PTSD symptoms is rated on a 0-4 (low to high) scale to determine symptom severity. The cutoff used to establish the presence of an individual symptom is a score of 2 or greater. Overall PTSD severity is computed by summing the totals for all items. Minimum and Maximum Values range from 0 to 80, higher scores mean higher levels of symptomatology.</description>
        <time_frame>Baseline,12 weeks, 3 and 6 months post-treatment</time_frame>
        <population>Participants were randomly assigned to CBI or SI. Participants with at least one post-baseline measure (end of treatment, 3 mo f/u, and/or 6 mo f/u) were included in HLM analysis. 28 participants (20 CBI, 10 SI) did not have post-baseline data on this scale. Mean scores / SDs are shown for all participants with data at each time point.</population>
        <group_list>
          <group group_id="O1">
            <title>Cognitive Behavioral Intervention</title>
            <description>12 weekly individual sessions consisting of psychoeducation, and cognitive and behavioral anger management strategies
Cognitive Behavioral Intervention: Includes individual therapy sessions using cognitive and behavioral strategies addressing problems with anger intensity / frequency / management.</description>
          </group>
          <group group_id="O2">
            <title>Supportive Intervention</title>
            <description>12 weekly individual sessions consisting of psychoeducation, problem-solving strategies, and support
Supportive Intervention: Includes individual therapy sessions using supportive and problem-solving strategies.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in PTSD Symptoms on the Clinician-Administered PTSD Scale (CAPS) for DSM-5 Total Score</title>
          <description>The CAPS-5 (updated for DSM-5) is a clinician administered structured interview for the assessment of DSM-5 PTSD. The CAPS has excellent reliability and validity and is widely used in PTSD treatment research. Each one of the DSM-5 PTSD symptoms is rated on a 0-4 (low to high) scale to determine symptom severity. The cutoff used to establish the presence of an individual symptom is a score of 2 or greater. Overall PTSD severity is computed by summing the totals for all items. Minimum and Maximum Values range from 0 to 80, higher scores mean higher levels of symptomatology.</description>
          <population>Participants were randomly assigned to CBI or SI. Participants with at least one post-baseline measure (end of treatment, 3 mo f/u, and/or 6 mo f/u) were included in HLM analysis. 28 participants (20 CBI, 10 SI) did not have post-baseline data on this scale. Mean scores / SDs are shown for all participants with data at each time point.</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="27"/>
                <count group_id="O2" value="37"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>12 Weeks</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="25"/>
                    <count group_id="O2" value="34"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="22.40" spread="11.99"/>
                    <measurement group_id="O2" value="24.24" spread="10.58"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 Month Post</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="19"/>
                    <count group_id="O2" value="30"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="22.37" spread="12.73"/>
                    <measurement group_id="O2" value="24.93" spread="12.54"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 Month Post</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="19"/>
                    <count group_id="O2" value="34"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21.89" spread="11.58"/>
                    <measurement group_id="O2" value="23.38" spread="12.41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>All randomized participants with at least one post-baseline assessment were used in the statistical analysis process.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.416</p_value>
            <p_value_desc>Threshold for statistical significance was 0.025.</p_value_desc>
            <method>ANCOVA</method>
            <method_desc>Hierarchical Linear Model (HLM) Repeated Measures Analysis of Covariance, Controlling for Baseline Score</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Change From Baseline in Anger on the Anger Consequences Questionnaire (ACQ)Total Score</title>
        <description>The ACQ is a brief self-report measure developed to assess the frequency of negative anger-related behavioral consequences. Internal consistencies of .75 to .91 were reported on the original 42 item version; the revised version shortened the measure to 33 items based on factor analysis. This scale includes items not covered by the other anger measures, including for example, trouble with the law, driving recklessly, getting into an accident, damaging relationships, etc. Minimum and Maximum Values range from 0 to 200, higher scores means more anger.</description>
        <time_frame>Baseline, Week 12, 3 and 6 months Post-treatment</time_frame>
      </outcome>
      <outcome>
        <type>Post-Hoc</type>
        <title>Overt Aggression Scale-Modified (OAS-M) - Irritability Scale</title>
        <description>Structured Interview that assesses verbal and physical aggressive behaviors. Minimum and Maximum Values range from 0 to 10, higher scores means more anger.</description>
        <time_frame>Baseline, Weeks 4, 8,12, 3 and 6 months post-treatment</time_frame>
        <population>Participants were randomly assigned to the CBI or SI using Wei and Stout's urn randomization. Participants with at least one post-baseline measure (i.e. one or more of 4wk, 8wk, end of treatment, 3 mo f/u, 6 mo f/u) were included in HLM analysis. Mean scores and SDs are shown for all participants with data at each assessment point.</population>
        <group_list>
          <group group_id="O1">
            <title>Cognitive Behavioral Intervention</title>
            <description>12 weekly individual sessions consisting of psychoeducation, and cognitive and behavioral anger management strategies
Cognitive Behavioral Intervention: Includes individual therapy sessions using cognitive and behavioral strategies addressing problems with anger intensity / frequency / management</description>
          </group>
          <group group_id="O2">
            <title>Supportive Intervention</title>
            <description>12 weekly individual sessions consisting of psychoeducation, problem-solving strategies, and support
Supportive Intervention: Includes individual therapy sessions using supportive and problem-solving strategies.</description>
          </group>
        </group_list>
        <measure>
          <title>Overt Aggression Scale-Modified (OAS-M) - Irritability Scale</title>
          <description>Structured Interview that assesses verbal and physical aggressive behaviors. Minimum and Maximum Values range from 0 to 10, higher scores means more anger.</description>
          <population>Participants were randomly assigned to the CBI or SI using Wei and Stout's urn randomization. Participants with at least one post-baseline measure (i.e. one or more of 4wk, 8wk, end of treatment, 3 mo f/u, 6 mo f/u) were included in HLM analysis. Mean scores and SDs are shown for all participants with data at each assessment point.</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="34"/>
                <count group_id="O2" value="39"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Week 4</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="31"/>
                    <count group_id="O2" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.000" spread="1.932"/>
                    <measurement group_id="O2" value="5.611" spread="1.961"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 8</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="25"/>
                    <count group_id="O2" value="33"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.960" spread="2.458"/>
                    <measurement group_id="O2" value="5.152" spread="2.063"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>End of Treatment (Week 12)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="25"/>
                    <count group_id="O2" value="34"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.440" spread="2.123"/>
                    <measurement group_id="O2" value="4.647" spread="2.130"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 Months Post</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="19"/>
                    <count group_id="O2" value="30"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.842" spread="1.608"/>
                    <measurement group_id="O2" value="4.333" spread="2.249"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 Months Post</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="19"/>
                    <count group_id="O2" value="34"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.684" spread="2.335"/>
                    <measurement group_id="O2" value="4.324" spread="2.070"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>All randomized participants with at least one post-baseline assessment were used in the statistical analysis process.
Data was also winsorized and log10 transformed to counter high levels of skewness.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.034</p_value>
            <p_value_desc>Threshold for statistical significance was 0.025.</p_value_desc>
            <method>ANCOVA</method>
            <method_desc>Hierarchical Linear Model (HLM) Repeated Measures Analysis of Covariance, Controlling for Baseline Score</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Post-Hoc</type>
        <title>Dimensions of Anger Response (DAR)</title>
        <description>The DAR is a 7 item self-report measure of anger reactions. It has been found to be reliable and sensitive to change. Higher scores reflect more severe anger. Scores can range from 0 to 28.</description>
        <time_frame>Weekly</time_frame>
        <posting_date>09/2020</posting_date>
      </outcome>
      <outcome>
        <type>Post-Hoc</type>
        <title>Overt Aggression Scale-Modified (OAS-M) - Aggressive Outbursts</title>
        <description>Structured Interview that assesses verbal and physical aggressive behaviors. Minimum and Maximum Values range from 0 to no maximum, higher scores means more anger.</description>
        <time_frame>Baseline, Weeks 4, 8,12, 3 and 6 months post-treatment</time_frame>
        <population>Participants were randomly assigned to the Cognitive Behavioral Intervention or the Supportive Intervention). Participants with at least one post-baseline measure (i.e. one or more of 4wk, 8wk, end of treatment, 3 mo f/u, 6 mo f/u) were included in HLM analysis. Mean scores and SDs are shown for all participants with data at each assessment point.</population>
        <group_list>
          <group group_id="O1">
            <title>Cognitive Behavioral Intervention</title>
            <description>12 weekly individual sessions consisting of psychoeducation, and cognitive and behavioral anger management strategies
Cognitive Behavioral Intervention: Includes individual therapy sessions using cognitive and behavioral strategies addressing problems with anger intensity / frequency / management</description>
          </group>
          <group group_id="O2">
            <title>Supportive Intervention</title>
            <description>12 weekly individual sessions consisting of psychoeducation, problem-solving strategies, and support
Supportive Intervention: Includes individual therapy sessions using supportive and problem-solving strategies.</description>
          </group>
        </group_list>
        <measure>
          <title>Overt Aggression Scale-Modified (OAS-M) - Aggressive Outbursts</title>
          <description>Structured Interview that assesses verbal and physical aggressive behaviors. Minimum and Maximum Values range from 0 to no maximum, higher scores means more anger.</description>
          <population>Participants were randomly assigned to the Cognitive Behavioral Intervention or the Supportive Intervention). Participants with at least one post-baseline measure (i.e. one or more of 4wk, 8wk, end of treatment, 3 mo f/u, 6 mo f/u) were included in HLM analysis. Mean scores and SDs are shown for all participants with data at each assessment point.</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="34"/>
                <count group_id="O2" value="39"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="34"/>
                    <count group_id="O2" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.473" spread="0.222"/>
                    <measurement group_id="O2" value="0.420" spread="0.179"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 4</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="31"/>
                    <count group_id="O2" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.329" spread="0.217"/>
                    <measurement group_id="O2" value="0.414" spread="0.252"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 8</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="25"/>
                    <count group_id="O2" value="33"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.253" spread="0.240"/>
                    <measurement group_id="O2" value="0.321" spread="0.238"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>End of Treatment (Week 12)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="25"/>
                    <count group_id="O2" value="34"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.215" spread="0.296"/>
                    <measurement group_id="O2" value="0.352" spread="0.257"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 Months Post</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="19"/>
                    <count group_id="O2" value="30"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.265" spread="0.245"/>
                    <measurement group_id="O2" value="0.275" spread="0.273"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 Months Post</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="19"/>
                    <count group_id="O2" value="34"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.285" spread="0.300"/>
                    <measurement group_id="O2" value="0.325" spread="0.238"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>All randomized participants with at least one post-baseline assessment were used in the statistical analysis process.
Data was also winsorized and log10 transformed to counter high levels of skewness.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.024</p_value>
            <p_value_desc>Threshold for statistical significance was 0.025.</p_value_desc>
            <method>ANCOVA</method>
            <method_desc>Hierarchical Linear Model (HLM) Repeated Measures Analysis of Covariance, Controlling for Baseline Score</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>4 years</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Cognitive Behavioral Intervention</title>
          <description>12 weekly individual sessions consisting of psychoeducation, and cognitive and behavioral anger management strategies
Cognitive Behavioral Intervention: Includes individual therapy sessions using cognitive and behavioral strategies addressing problems with anger intensity / frequency / management.</description>
        </group>
        <group group_id="E2">
          <title>Supportive Intervention</title>
          <description>12 weekly individual sessions consisting of psychoeducation, problem-solving strategies, and support
Supportive Intervention: Includes individual therapy sessions using supportive and problem-solving strategies.</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>MedDRA (10.0)</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="47"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="45"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="47"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="45"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Death</sub_title>
                <description>Cardiac attack</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="47"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="45"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Panic Attack</sub_title>
                <description>Panic Attack</description>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="47"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="45"/>
              </event>
              <event>
                <sub_title>Death</sub_title>
                <description>Veteran accidentally overdosed on cocaine and fentanyl</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="45"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="45"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>M. Tracie Shea, PhD</name_or_title>
      <organization>Providence VA Medical Center</organization>
      <phone>401-273-7100 ext 6248</phone>
      <email>MaryTracie.Shea@va.gov</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

